Keren Wang
Impact in
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
-
- Computational Drug Discovery Methods
Papers in
- Pharmacology 24
- Cholinesterase and Neurodegenerative Diseases 24
-
- Computational Drug Discovery Methods 18
- Co-authors
- Zhipei Sang (18 shared papers)Wenmin Liu (19 shared papers)Zhenghuai Tan (12 shared papers)Jian Shi (11 shared papers)Lintao Yu (7 shared papers)Lei Tang (5 shared papers)Gaofeng Zhu (8 shared papers)Jianghong Dong (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (9 papers)Bioorganic Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Muscle & Nerve (2 papers)Bioorganic & Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Keren Wang
55 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Pharmacology 650
- Computational Theory and Mathematics 395
- Complementary and alternative medicine 151
- Cancer Research 211
- Physiology 298
Countries citing papers authored by Keren Wang
This map shows the geographic impact of Keren Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Wang more than expected).
Fields of papers citing papers by Keren Wang
This network shows the impact of papers produced by Keren Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Wang. The network helps show where Keren Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Keren Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 91 | |
| 2 | 2017 | 90 | |
| 3 | 2019 | 86 | |
| 4 | 2019 | 73 | |
| 5 | 2018 | 73 | |
| 6 | 2017 | 64 | |
| 7 | 2020 | 62 | |
| 8 | 2015 | 57 | |
| 9 | 2019 | 57 | |
| 10 | 2018 | 56 | |
| 11 | 2019 | 50 | |
| 12 | 2020 | 39 | |
| 13 | 2012 | 37 | |
| 14 | 2017 | 30 | |
| 15 | 2015 | 30 | |
| 16 | 2017 | 30 | |
| 17 | 2017 | 29 | |
| 18 | Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. | 2014 | 28 |
| 19 | 2023 | 26 | |
| 20 | 2021 | 24 |
About Keren Wang
Keren Wang is a scholar working on Pharmacology, Computational Theory and Mathematics, Molecular Biology, Physiology and Cancer Research, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (24 papers), Computational Drug Discovery Methods (18 papers), Alzheimer's disease research and treatments (15 papers), Medicinal Plants and Neuroprotection (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers), Chemical synthesis and alkaloids (4 papers) and Peripheral Neuropathies and Disorders (4 papers). The work is most often cited by research in Pharmacology (650 citations), Computational Theory and Mathematics (395 citations), Complementary and alternative medicine (151 citations), Cancer Research (211 citations) and Physiology (298 citations). Keren Wang has collaborated with scholars based in China, United States and India. Frequent co-authors include Zhipei Sang, Wenmin Liu, Zhenghuai Tan, Jian Shi, Lintao Yu, Lei Tang, Gaofeng Zhu, Jianghong Dong, Zhaoying Yang and Yuqin Ye. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic Chemistry, Bioorganic & Medicinal Chemistry Letters, Muscle & Nerve and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.